Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations

被引:90
作者
Ungaro, F [1 ]
De Rosa, G [1 ]
Miro, A [1 ]
Quaglia, F [1 ]
机构
[1] Univ Naples Federico II, Fac Farm, Dipartimento Chim Farmaceut & Tossicol, I-80131 Naples, Italy
关键词
polyethylenimine; copper (II) complex; oligonucleotide; spectrophotometry; sustained release;
D O I
10.1016/S0731-7085(02)00571-X
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Polyethylenimine (PEI) is a cationic polymer that can be associated to oligonuclotides to promote their transfection both in vitro and in vivo. The controlled release of oligonucleotide/polyethylenimine complexes from biodegradable systems can result in an increased cellular internalisation of the oligonucleotide and a reduced cytotoxicity of the complex. This effect strongly depends on the amount of PEI loaded in and released from the delivery system. In this work we describe a rapid, sensitive and reproducible spectrophotometric method for the quantitative analysis of PEI by itself or in the presence of an associated oligonucleotide. PEI does not possess chromophores, hence the determination by ordinary spectrophotometry is not possible. However, upon addition of copper (II) ions, PEI forms a dark blue cuprammonium complex that can be detected by UV-vis spectrophotometry. The optimum conditions in terms of optical parameters, copper (II) concentration required for a quantitative PEI complexation, and the most suitable medium for the reaction were ascertained. A linear relationship (r(2) = 0.9997) between absorbance and amounts of PEI was found at lambda(max) of 285 nm over the concentration range 5.0-50.0 mug ml(-1). The detection limit (QOD) was 4.0 mug ml(-1). The method was validated for the quantitation of PEI in the presence of an oligonucleotide, which absorbs at 285 nm as well. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:143 / 149
页数:7
相关论文
共 16 条
  • [1] Non-viral gene transfer: Applications in developmental biology and gene therapy
    Abdallah, B
    Sachs, L
    Demeneix, BA
    [J]. BIOLOGY OF THE CELL, 1995, 85 (01) : 1 - 7
  • [2] A powerful nonviral vector for in vivo gene transfer into the adult mammalian brain: Polyethylenimine
    Abdallah, B
    Hassan, A
    Benoist, C
    Goula, D
    Behr, JP
    Demeneix, BA
    [J]. HUMAN GENE THERAPY, 1996, 7 (16) : 1947 - 1954
  • [3] A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE
    BOUSSIF, O
    LEZOUALCH, F
    ZANTA, MA
    MERGNY, MD
    SCHERMAN, D
    DEMENEIX, B
    BEHR, JP
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) : 7297 - 7301
  • [4] The use of synthetic polymers for delivery of therapeutic antisense oligodeoxynucleotides
    Chirila, TV
    Rakoczy, PE
    Garrett, KL
    Lou, X
    Constable, IJ
    [J]. BIOMATERIALS, 2002, 23 (02) : 321 - 342
  • [5] Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes
    De Rosa, G
    Quaglia, F
    La Rotonda, MI
    Appel, M
    Alphandary, H
    Fattal, E
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2002, 91 (03) : 790 - 799
  • [6] HOWELL JA, 1997, HDB INSTRUMENTAL TEC, P481
  • [7] Co-delivery of an antisense oligonucleotide and 5-fluorouracil using sustained release poly (lactide-co-glycolide) microsphere formulations for potential combination therapy in cancer
    Hussain, M
    Beale, G
    Hughes, M
    Akhtar, S
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 234 (1-2) : 129 - 138
  • [8] Spectrophotometric determination of alendronate in pharmaceutical formulations via complex formation with Fe(III) ions
    Kuljanin, J
    Jankovic, I
    Nedeljkovic, J
    Prstojevic, D
    Marinkovic, V
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2002, 28 (06) : 1215 - 1220
  • [9] Cellular delivery of antisense oligonucleotides
    Lebedeva, I
    Benimetskaya, L
    Stein, CA
    Vilenchik, M
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 50 (01) : 101 - 119
  • [10] Gene therapy - Therapeutic approaches and implications
    Mhashilkar, A
    Chada, S
    Roth, JA
    Ramesh, R
    [J]. BIOTECHNOLOGY ADVANCES, 2001, 19 (04) : 279 - 297